THR Q1 2026 Earnings Slight EPS Miss Fails to Dampen Investor Sentiment Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline PANL Q1 2026 Earnings EPS Beats Estimates Amid Broader Market Headwinds Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise MBINL Q1 2026 Earnings Preferred Shares Beat EPS Estimates on Strong Core Performance MFAO Q1 2026 Earnings Slight EPS Miss Amid Stable Business Conditions ARTL Q4 2025 Earnings Narrowing Loss Surprises but Revenue Remains Absent MSGE Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher Targa Resources Q1 2026 Earnings EPS Misses Estimates Amid Operational Strength CDNS Q1 2026 Earnings Solid EPS Beat Drives 422 Share Gain PTGX Q1 2026 Earnings Surprise Profit as Pipeline Advances Stock Edges Lower Toro Company Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency WHLRD Q2 2024 Earnings Limited Data Preferred Stock Reports EPS of 365